• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NIPRO CORPORATION (ODATE) NIPRO CELLENTIA DIALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NIPRO CORPORATION (ODATE) NIPRO CELLENTIA DIALYZER Back to Search Results
Model Number DD+CT21H
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 07/20/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Initial investigation report attached is on retained samples only.(b)(4).
 
Event or Problem Description
On (b)(6) 2019, with 1hr and 20 minutes left into a 4.25hr treatment, the system clotted and the staff was unable to return the patient's blood.The clinic set up a new system and patient was able to complete the remaining 1hr and 20 minutes.Patient used to receive heparin but was stopped due to vaginal bleeding.Staff did not record the lot number for the dialyzer used.Clinic checked the patient's hemoglobin levels and they were 9.2g/dl.(dialyzer was disposed) patient has a cvc(dialysis catheter), bfr is 400, dfr is 800.On (b)(6): 2nd incident, same patient, with 1hr and 30 minutes left into a 4.25hr treatment, machine alarmed for high venous pressure, clots were noted on the bloodlines and the dialyzer, but the staff was able to return the patient's blood.Patient received 2000 units of bolus heparin, clinic is giving the patient 100ml of heparin flushes every hour, and will do continuous flushes of 300ml/hr with her next scheduled treatment.Hemoglobin levels were checked and the results were 9 g/dl.Patient is now on max does of aranesp.
 
Additional Manufacturer Narrative
Initial investigation report attached is on retained samples only.(b)(6)2019: final investigation report on actual used sample is attached.- attachment: [odt report 48359 (190065) 20190801.Pdf, odt report 48359 (190065) 20190909.Pdf].
 
Event or Problem Description
On (b)(6) 2019, with 1hr and 20 minutes left into a 4.25hr treatment, the system clotted and the staff was unable to return the patient's blood.The clinic set up a new system and patient was able to complete the remaining 1hr and 20 minutes.Patient used to receive heparin but was stopped due to vaginal bleeding.Staff did not record the lot number for the dialyzer used.Clinic checked the patient's hemoglobin levels and they were 9.2g/dl.(dialyzer was disposed) patient has a cvc(dialysis catheter), bfr is 400, dfr is 800 on july 23: 2nd incident, same patient, with 1hr and 30 minutes left into a 4.25hr treatment, machine alarmed for high venous pressure, clots were noted on the bloodlines and the dialyzer, but the staff was able to return the patient's blood.Patient received 2000 units of bolus heparin, clinic is giving the patient 100ml of heparin flushes every hour, and will do continuous flushes of 300ml/hr with her next scheduled treatment.Hemoglobin levels were checked and the results were 9 g/dl.Patient is now on max does of aranesp.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NIPRO CELLENTIA DIALYZER
Common Device Name
DIALYZER
Manufacturer (Section D)
NIPRO CORPORATION (ODATE)
8-7 hanuki-yachi, nilda-aza
ohdate-shi, akita, 01857 94
JA  0185794
MDR Report Key8895285
Report Number9610987-2019-00008
Device Sequence Number1561284
Product Code KDI
UDI-Device Identifier00383790004411
UDI-Public00383790004411
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K160444
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source user facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2022
Device Model NumberDD+CT21H
Device Lot Number19D01C
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/06/2019
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/24/2019
Supplement Date Received by Manufacturer07/24/2019
Initial Report FDA Received Date08/14/2019
Supplement Report FDA Received Date09/12/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-